Is Healthcare Realty Trust Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NYSE: HR) stock is to Hold HR stock.
Out of 2 analysts, 0 (0%) are recommending HR as a Strong Buy, 0 (0%) are recommending HR as a Buy, 2 (100%) are recommending HR as a Hold, 0 (0%) are recommending HR as a Sell, and 0 (0%) are recommending HR as a Strong Sell.
What is HR's forecast return on equity (ROE) for 2023-2026?
(NYSE: HR) forecast ROE is N/A, which is considered weak.
What is HR's Price Target?
According to 2 Wall Street analysts that have issued a 1 year HR price target, the average HR price target is $20.50, with the highest HR stock price forecast at $24.00 and the lowest HR stock price forecast at $17.00.
On average, Wall Street analysts predict that Healthcare Realty Trust's share price could reach $20.50 by Aug 22, 2024. The average Healthcare Realty Trust stock price prediction forecasts a potential upside of 37.95% from the current HR share price of $14.86.
What is HR's forecast return on assets (ROA) for 2023-2026?
(NYSE: HR) forecast ROA is N/A, which is lower than the forecast US REIT - Healthcare Facilities industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.